Myositis
-
Subject Areas on Research
- 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.
- 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
- A 55-year-old man with fever, renal failure, and hip pain.
- A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy.
- A comparative study of the effect of arterial and venous occlusion after various periods of ischemia.
- Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
- Antifibrotic Therapy: Is There a Role in Myositis-Interstitial Lung Disease?
- Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
- Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
- Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
- Automatic analysis of the electromyographic interference pattern. Part II: Findings in control subjects and in some neuromuscular diseases.
- BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
- Causes of creatine kinase levels greater than 1000 IU/L in patients referred to rheumatology.
- Chimerism in myositis.
- Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.
- Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
- Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
- Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
- Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies.
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
- Evaluation of muscles affected by myositis using magnetic resonance elastography.
- Evaluation of penicillin and hyperbaric oxygen in the treatment of streptococcal myositis.
- Extracellular matrix disruption and pain after eccentric muscle action.
- Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
- Gemcitabine-induced radiation recall myositis.
- Genetic and environmental risk factors for idiopathic inflammatory myopathies.
- Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.
- HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies.
- Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.
- Index of suspicion.
- Interesting image. F-18 fluorodeoxyglocose positron emission tomography/computed tomography in the diagnosis of chronic myopathic sarcoidosis.
- Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.
- International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.
- International consensus on preliminary definitions of improvement in adult and juvenile myositis.
- International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
- Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
- Managing contraception and pregnancy in the rheumatologic diseases.
- Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.
- Myositis in children.
- Necrotizing fasciitis and myositis caused by group A streptococci. Epidemiology, diagnosis, and treatment of "flesh-eating bacteria".
- Necrotizing myofasciitis: an atypical cause of "acute abdomen" in an immunocompromised child.
- Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale.
- Pectoralis pyomyositis: an unusual cause of chest wall pain in a patient with diabetes mellitus and rheumatoid arthritis.
- Phenotype standardization for statin-induced myotoxicity.
- Polymyositis after propylthiouracil treatment for hyperthyroidism.
- Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.
- Profound muscle weakness and hypokalemia due to clay ingestion.
- Pyomyositis and polyarticular septic arthritis from Hemophilus influenzae in a nonimmunocompromised adult.
- Pyomyositis in a temperate climate. Presentation, diagnosis, and treatment.
- Pyomyositis: characteristics at CT and MR imaging.
- Quantitative EMG in inflammatory myopathy.
- Real world utilization of the myositis autoantibody panel.
- Recent advances in juvenile idiopathic inflammatory myopathies.
- Rheumatologic manifestations of cancer.
- STAT3 Regulates Self-Renewal of Adult Muscle Satellite Cells during Injury-Induced Muscle Regeneration.
- Spontaneous pyomyositis in a patient with Felty's syndrome: diagnosis using computerized tomography.
- Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies.
- The inflammatory milieu in idiopathic inflammatory myositis.
- The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.
- Update on outcome assessment in myositis.
- Update: biomarkers for idiopathic inflammatory myopathies.
- Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy.
- Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
- [Idiophatic inflammatory myophaties: its asociation with liver disorders].
-
Keywords of People
- Allen, Nancy Bates, Professor Emeritus of Medicine, Medicine, Rheumatology and Immunology
- Dvergsten, Jeffrey Arthur, Associate Professor of Pediatrics, Pediatrics, Rheumatology
- Gonzalez, Natalia Laura, Assistant Professor of Neurology, Neurology, Neuromuscular Disease